Introduction {#sec1-1}
============

Infections due to *Candida* species are increasing, as also their resistance to antifungal drugs. The clinical entities of candidiasis vary with immune status. Immunocompromised patients are more prone to develop both superficial and serious life-threatening *Candida* infections.\[[@ref1][@ref2]\] Significant increase in the incidence of candidiasis and the emergence of antifungal resistance\[[@ref3]\] contributes to long hospital stay, health-care cost, morbidity and mortality. The increase in resistant strains and adverse reaction of the available antifungals necessitates a search for new targets for new antifungal agents.\[[@ref4][@ref5]\] The World Health Organization states that \>80% of the world's population relies on traditional medicine for their primary health-care needs. In view of possible difficulties, strong incentives are there to develop new, cost-effective, nontoxic, broad-spectrum natural fungicides.

*Curcuma longa* L., commonly known as "turmeric," belongs to *Zingiberaceae* family is an ancient coloring spice of Asia and has been conventionally used as an antimicrobial agent as well as an insect repellant.\[[@ref6][@ref7]\] The polyphenolic components of *C*. *longa* are collectively named curcuminoids, which include mainly diferuloylmethane curcumin (77%), demethoxycurcumin (17%) and bisdemethoxycurcumin (3%).\[[@ref8]\] The biological activities of turmeric are attributed to curcumin, a bioactive polyphenol component, predominantly present in turmeric. Several reports of extended-spectrum antimicrobial activity of curcumin are available. Its safety has been proved in animal studies and in Phase I clinical trials, even doses up to 12 g/day were found to be nontoxic.\[[@ref9]\] However, its poor bioavailability has been a major drawback of this potentially valuable therapeutic agent. Low aqueous solubility, tendency to degrade in the gastrointestinal tract in the physiological environment, high rate of metabolism, and rapid systemic elimination are the causes for its low bioavailability. Either very low or undetectable levels of curcumin have been noted in blood by oral administration of curcumin. To achieve considerable therapeutic effects on the human body, one has to swallow 24--40 curcumin capsules of 500 mg each. These doses are too high and hence not feasible to be incorporated in clinical trial.\[[@ref9][@ref10]\] To utilize the potential benefits of this wonder chemical, approaches based on the use of adjuvants, chelating of curcumin with metals or combining with other dietary agents, have been investigated.

The antifungal effect of curcumin is due to the downregulation of 5,6 desaturase (ERG3) leading to significant reduction in ergosterol of fungal cell. As a result, biosynthetic precursors of ergosterol accumulate, leading to cell death through generation of reactive oxygen species (ROS).\[[@ref11]\] Reduction in proteinase secretion and alteration of membrane-associated properties of ATPase activity are other possible mechanisms involved in fungicidal action of curcumin.\[[@ref12]\] Inhibition of H+-extrusion resulting in intracellular acidification can be possible mechanism for cell death of *Candida* species.\[[@ref13]\] Curcumin inhibits hyphal formation by targeting the global suppressor thymidine uptake 1.\[[@ref14]\]

Silver ions have long been known to possess a broad spectrum of antimicrobial activities.\[[@ref15]\] Silver is more toxic to microbes and less toxic to mammalian cells. Silver nanoparticles (Ag-NPs) show good antifungal effects, by producing ROS such as superoxide anion (O~2~^−^), hydroxyl radical (OH) and singlet oxygen with subsequent oxidative damage.\[[@ref16]\] It has been reported that there is a loss of membrane integrity after treatment with Ag-NPs.\[[@ref17]\]

Materials and Methods {#sec1-2}
=====================

Preparation of curcumin solution {#sec2-1}
--------------------------------

Curcumin (≃% w/w) was purchased from Grenera, India. The curcumin solution was prepared according to the standard protocol.\[[@ref18]\] Five hundred milligrams of curcumin powder was added to 100 ml of sterile deionized water. The mixture was heated at 80°C for 30 min. The heterogeneous mixture was filtered through Whatman filter paper no. 1 to get a homogeneous solution of curcumin in water.

Preparation of curcumin-silver nanoparticle {#sec2-2}
-------------------------------------------

A total of 10 ml of silver nitrate (AgNO~3~) (Merck-CAS7761-88-8) 0.1 M and 3 ml curcumin solution were mixed in a 50 ml conical flask and heated in a water bath for 1 h at 60°C.\[[@ref19]\] The formation of the Ag-NPs was monitored and determined through a change of appearance (color) of the mixture that changed from light yellow to brownish \[[Figure 1](#F1){ref-type="fig"}\]. The synthesis was further validated using ultraviolet-visible (UV-vis) spectroscopy (UV-2450, Shimadzu, Japan). The solution was centrifuged at 9000 rpm for 15 min. Then, the product was washed with ethanol and was lyophilized (Free Zone 6, USA) for 24 h to obtain the purified curcumin-Ag-NPs (C-Ag-NPs). A stock of 1 mg/ml of C-Ag-NPs was prepared in deionized water.

![Formation of curcumin silver nanoparticles](AYU-39-182-g001){#F1}

Microorganisms {#sec2-3}
--------------

Microbial type culture collection centre (MTCC) strains of Candida species -- *Candida albicans* (MTCC 3017), *Candida glabrata* (MTCC 3019) and *Candida krusei* (MTCC 9215) were used. These strains were obtained from MTCC, Chandigarh, India and used as quality controls. Twenty-one fluconazole-resistant *Candida* strains isolated from different samples of HIV-infected cases were also included in the study. Fluconazole resistance was confirmed by antifungal susceptibility testing according to the Clinical and Laboratory Standards Institute (CLSI) standards.\[[@ref20]\] The 21 strains included 5 *C*. *albicans*, 5 *C*. *tropicalis*, 5 *C*. *krusei*, 3 *C*. *glabrata*, 2 *C*. *parapsilosis* and 1 *C*. *kefyr*.

Evaluation of antifungal activity-broth dilution method {#sec2-4}
-------------------------------------------------------

The minimum inhibitory concentration (MIC) to the fungal strains was determined by the resazurin microtiter method\[[@ref21]\] with slight modifications. One hundred microliters of C-Ag-NPs was added into the first row of the sterile 96 well plate. To all other wells, 50 μL of RPMI 1640 broth was added. Serially descending concentrations were prepared with final volume of 50 μL in each well. Ten microliters of resazurin indicator solution was added. Ten microliters of inoculum adjusted to 0.5 McFarland standard was added, mixed and incubated at 37°C for 24--48 h. The blue color indicated the inhibition of growth. The lowest concentration which inhibited the visual growth was recorded as MIC. All the analyses were performed in triplicate. Amphotericin B (0.0313--16 μg/ml) and RPMI 1640 broth without antifungal agents were used as negative and positive controls, respectively.

Evaluation of antifungal activity-agar diffusion method {#sec2-5}
-------------------------------------------------------

The antifungal activity against the fungal strains was done according to the CLSI guidelines M44 A, 2008.\[[@ref20]\] Wells of standard diameter (5 mm) were bored in the modified MHA using sterile well puncher. A lawn culture was done with inoculum already adjusted to 0.5 McFarland standard (1.5 × 10^8^ colony-forming unit/mL). Ten microliters, 20 μL, and 50 μL of Ag-NPs were added to the respective wells. The concentration of C-Ag-NPs in each well was 10 μg, 20 μg, and 50 μg, respectively. Fifty microliters of curcumin and 0.1 M AgNO~3~ were included as controls. The concentration of curcumin in 50 μL of curcumin solution was 250 μg. The plates were then incubated at 37°C for approximately 18--24 h. The diameter of zones of inhibition produced by varied concentrations of C-Ag-NPs against the test organisms was measured after overnight incubation. Next day, the diameter of zones of inhibition produced by varied concentrations of the extracts against the test organisms was measured.

Results {#sec1-3}
=======

UV-vis spectroscopy is the most common and reliable technique for the preliminary characterization of synthesized nanoparticles and stability of Ag-NPs.\[[@ref22]\] Any peak at the range between 400 and 440 nm shows the production of Ag-NPs.\[[@ref23]\] In the present study, it showed the peak at 421 nm \[[Figure 2](#F2){ref-type="fig"}\].

![Ultraviolet-visible spectrum](AYU-39-182-g002){#F2}

[Table 1](#T1){ref-type="table"} and [Figure 3](#F3){ref-type="fig"} show the antifungal activity of C-AgNP, curcumin, and AgNO~3~ against the MTCC strains and clinical isolates of *Candida* species. C-AgNP showed a better antifungal activity compared to curcumin and AgNO~3~ solution. *C*. *glabrata* and *C*. *albicans* were the most inhibited. The zone diameter obtained with 50 μL of C-Ag-NPs for *C*. *glabrata* and *C*. *albicans* was 20.6 ± 0.8 and 20.1 ± 0.8, respectively. *C*. *tropicalis* was the least inhibited with a zone of inhibition of 16.4 ± 0.7. An increase in diameter of the zone size was noticed with increase in concentration. Fifty microliters of curcumin solution inhibited the growth of all the MTCC strains tested. However, the diameter of zone of inhibition was lesser than C-Ag-NPs. As in curcumin solution, AgNO~3~ solution also inhibited all the MTCC strains under study.

###### 

The antifungal activity of the C-Ag-NPs against MTCC and fluconazole resistant Candida strains

  Candida species        Concentration                                     
  ---------------------- --------------- ---------- ----------- ---------- ----------
  Zone diameter (mm)                                                       
  *C. albicans* (MTCC)   3.1±0.18        10±0.11    20.1±0.8    1±0.22     0.8±0.55
  *C. albicans*          2.1±0.2         9±0.21     20±0.2      0.8±0.2    0.6±0.55
  *C. glabrata* (MTCC)   5.2±0.42        12±0.11    20.6±0.8    0.8±0.02   0.7±0
  *C. glabrata*          4.2±0.4         12±0.18    20.5±0.8    1.2±0.12   0.7±0.03
  *C.krusei* (MTCC)      3.7±0.63        9±0.4      15.1±0.3    1.6±0.12   1.5±0.01
  *C.krusei*             3.7±0.23        9.5±0.3    19.5±0.1    1.6±0.62   1.5±0.01
  *C. tropicalis*        2.5±0.11        8.6±0.02   16.4±0.7    0.6±0.02   0.4±0.85
  *C. parapsilosis*      1.8±0.2         8.1±0.12   18.4±0.14   1.1±0.14   1±0.41
  *C. kefyr*             2.6±0.02        7.8±0.23   19.5±0.22   0.8±0.02   0.9±0.1

MTCC: Microbial Type Culture Collection Centre, C-Ag-NPs: Curcumin -silver nanoparticles, AgNO~3~: Silver nitrate, *C. albicans: Candida albicans, C. glabrata: Candida glabrata, C. krusei: Candida krusei, C. tropicalis: Candida tropicalis, C. parapsilosis: Candida parapsilosis, C. kefyr: Candida kefyr*
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MIC was calculated as the lowest concentration at which the visual growth was inhibited. The MIC for *C*. *glabrata* and *C*. *albicans* was 31.2 μg/ml and 62.5 μg/ml, respectively. For *C*. *tropicalis*, the MIC was recorded as 250 μg/ml. The MIC values for *C*. *parapsilosis*, *C*. *krusei*, and *C*. *kefyr* were 125 μg/ml, 125 μg/ml and 62.5 μg/ml, respectively.

Discussion {#sec1-4}
==========

In this study, C-Ag-NPs exhibited an excellent antifungal activity against all the fungal strains tested; however, the inhibitory effects differed with regard to different fungal species. The least inhibited was *C*. *tropicalis*. The activity was dose dependent and the inhibition zone diameter increased with increase in concentration of curcumin.

Ungphaiboon *et al*. showed that the methanol extract of turmeric exhibited antifungal activity against *Cryptococcus neoformans* and *C*. *albicans* with MIC values of 128 and 256 μg/mL, respectively.\[[@ref24]\] Another study by Neelofar *et al*. described excellent anticandidal activity of curcumin against 4 ATCC strains and 10 clinical isolates of *Candida* species. The MIC values range from 250 to 2000 μg/mL.\[[@ref12]\] Curcumin was found to be active against fluconazole-resistant *Candida* strains. The MIC~90~ values for sensitive and resistant strains were 250--650 and 250--500 μg/mL, respectively.\[[@ref13]\] Previous studies of antifungal activity of C-Ag-NPs against *Candida* species, especially fluconazole resistant strains, are not available.

Curcumin markedly prevents the adhesion of *Candida* species to buccal epithelial cells and it was found to be more effective compared to fluconazole.\[[@ref25]\] Studies also proved that curcumin-mediated photodynamic therapy can reduce the biofilm biomass of *C*. *albicans*, *C*. *glabrata*, and *C*. *tropicalis*. Synergistic activity was noted with curcumin, fluconazole and amphotericin B against *Candida* species and can be due to the accumulation of ROS.\[[@ref11][@ref14]\]

The low bioavailability of curcumin, low aqueous solubility, tendency to degrade in the gastrointestinal tract in the physiological environment, high rate of metabolism and rapid systemic elimination can be solved by making it react with silver ions. Several antibiotics use silver compounds such as metallic silver, AgNO~3~, silver sulfadiazine for treatment of burns, wounds and several infections\[[@ref26]\] and are available in the market as topical agents. However, there are data regarding toxic effect of silver ions at 5 mM concentration. Hence, by the formation of C-Ag-NPs, the toxic effect due to high concentration can be reduced and also the microbicidal activity can be improved.

Conclusion {#sec1-5}
==========

It can be concluded from the results of this study that curcumin Ag-NPs are very effective anticandidal agents. Thus, it can contribute in global problem of the emergence of resistance and overcome the limitations, namely, toxicity and health-care costs. The antifungal potential of C-Ag-NPs is high as outlined, and indisputably the prospect is great to develop it as a topical chemotherapeutic agent.

Financial support and sponsorship {#sec2-6}
---------------------------------

Nil.

Conflicts of interest {#sec2-7}
---------------------

There are no conflicts of interest.
